Video: Who Am I?| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: pediatric rheumatology

What Does Being an ACR Master Mean? ACR’s 2024 Master’s Class Honored

Patrice Fusillo  |  November 22, 2024

The ACR honored 19 members for outstanding contributions to the ACR and the field of rheumatology.

Filed under:ACR ConvergenceAwardsCareerMeeting Reports Tagged with:ACR Convergence 2024AwardsCareer

ACR Honors Distinguished Fellows: Class of 2024

Patrice Fusillo  |  November 18, 2024

At ACR Convergence 2024, the ACR honored clinical and research fellows in programs from New York to California and points between.

Filed under:ACR ConvergenceAwardsCareerMeeting ReportsProfiles Tagged with:ACR Convergence 2024Awardsdistinguished fellowFellowsfellowship

Rheum After 5: Dr. Elizabeth Hazel, Olympian

Carol Patton  |  November 11, 2024

Dr. Elizabeth Hazel reflects on her experience as a Canadian swimming competitor in the 1992 Summer Olympics.

Filed under:ProfilesRheum After 5 Tagged with:Dr. Elizabeth Hazel

AC&R Study Summary: Standardizing Treatment for Moderately Severe JDM

By Matthew A. Sherman, MD, MHSc, & Stacey E. Tarvin, MD, MS  |  November 10, 2024

Why was this study done? Juvenile dermatomyositis (JDM) is the most common type of idiopathic inflammatory myopathy in childhood, and most patients have a chronic disease course requiring prolonged administration of systemic glucocorticoids and immunosuppressive agents. The initial management for patients with moderately severe JDM is relatively standardized, typically including methotrexate and systemic glucocorticoids with…

Filed under:Biologics/DMARDsClinical Criteria/GuidelinesConditionsDrug UpdatesMyositisResearch Rheum Tagged with:juvenile dermatomyositisReading Rheum

Insight into the ACR’s Commitment to an Inclusive Committee Composition

Kanika Monga, MD, FACR  |  October 9, 2024

“While our group carefully considered your application, I regret to inform you that you were not selected this year to serve as a committee volunteer.” When the email arrived, gently delivering the news that my application to volunteer with the ACR on a committee had not been accepted, my initial reaction was to dismiss it…

Filed under:From the College Tagged with:ACR standing committeesDiversity

Case Report: Voriconazole-Induced Periostitis

Amanda Moyer, MD, & Tamiko Katsumoto, MD  |  October 8, 2024

In this case report, a patient with voriconazole-induced periostitis exhibits classic symptoms & elevated ALP levels, which quickly resolve following the discontinuation of voriconazole.

Filed under:ConditionsOsteoarthritis and Bone Disorders Tagged with:bone paincase reportskeletal fluorosisvoriconazolevoriconazole-induced periostitis

Kidney Biopsy in Lupus Nephritis

Ruth Jessen Hickman, MD  |  June 17, 2024

SAN DIEGO—As part of a Nov. 14 session on lupus nephritis at ACR Convergence 2023, Simone Appenzeller, MD, PhD, shared perspectives on the importance of biopsy to inform its diagnosis, prognosis and treatment, with an emphasis on childhood disease. Prompt diagnosis and treatment of lupus nephritis is perhaps even more important for children than for…

Filed under:ACR ConvergenceConditionsSystemic Lupus Erythematosus Tagged with:ACR Convergence 2023biopsyLupus nephritisSLE Resource Center

ACR Delegation to Lead Several Resolutions at June AMA House of Delegates Meeting

From the College  |  May 21, 2024

The ACR will lead five other specialty societies on a resolution supporting pediatric specialty care and will co-lead resolutions addressing Medicare Advantage Part B drug coverage, white bagging mandates, state prescription drug affordability boards and impacts of alternative funding programs on access to care.

Filed under:American College of RheumatologyLegislation & AdvocacyPractice Support Tagged with:ACR advocacyAMA House of Delegates (HOD)

Case Report: Complicated Presentation Eventually Explained by Rare Syndrome

Geoffrey E. Thiele, MD, & Iris Reyhan, MD  |  April 10, 2024

Pachydermoperiostosis (PDP), also known as Touraine-Solente-Golé syndrome or primary hypertrophic osteoarthropathy, is a rare syndrome that can be inherited as autosomal dominant, autosomal recessive, or sporadically. This progressive disease primarily affects males, who tend to have more severe features than females. PDP usually occurs during adolescence, often starting around puberty.1 The main clinical features are…

Filed under:ConditionsOther Rheumatic Conditions Tagged with:case reportCrohn's diseasePachydermoperiostosisprimary hypertrophic osteoarthropathyTouraine-Solente- Golé syndrome

When to Check Drug Levels & Why

Stephen J. Balevic, MD, PhD, RhMSUS  |  March 7, 2024

Checking blood levels of commonly used disease-modifying anti-rheumatic drugs (DMARDs) has gained widespread attention in the rheumatology community, even resulting in a recent guidance document from EULAR for biologics.1 Although a highly useful tool, drug level measurement in rheumatology is not without challenges; many of our drugs violate the basic principles of pharmacology that we…

Filed under:Biologics/DMARDsConditionsDrug UpdatesRheumatoid ArthritisSystemic Lupus Erythematosus Tagged with:adalimumabadherenceazathioprinedosagedosage adjustmentdrug levelsetanerceptHYDROXYCHLOROQUINEinfliximabmycophenoloateSLE Resource Centertherapeutic drug monitoring

  • « Previous Page
  • 1
  • …
  • 29
  • 30
  • 31
  • 32
  • 33
  • …
  • 95
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences